Company The Searle Company Limited

Equities

SEARL

PK0061701014

Pharmaceuticals

End-of-day quote Pakistan S.E. 06:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
56.53 PKR -1.46% Intraday chart for The Searle Company Limited -6.87% +9.81%

Business Summary

The Searle Company Limited is a Pakistan-based company, which is engaged in the manufacture of pharmaceuticals and other consumer products. The Company’s product categories include pharmaceutical, biopharmaceutical, nutraceutical, nutrition, consumer, and medical devices and disposables. The Company's product portfolio in the pharmaceutical range includes therapeutic areas, such as cardiovascular, respiratory care, gastroenterology, pain management, central nervous system (CNS), ortho care, neuropsychiatry, probiotics, antibiotics, and nutritional care. Its pharmaceutical products include Analgesic & Muscle-Relaxant, Anti-Allergy & Anti-Tussive, Anti-Anemic, Anti-Chelating, Anti-infective, Anti-Neoplastic, Anti-Thrombotic, Cardiovascular, Endocrinology & Metabolism. It also focuses on specialty generic branded portfolios and targeting differentiated products. Its subsidiaries include IBL HealthCare Limited, Searle Pharmaceuticals (Private) Limited, and others.

Number of employees: 2,716

Sales per Business

PKR in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
29,910 100.0 % 33,970 100.0 % +13.57%

Sales per region

PKR in Million2022Weight2023Weight Delta
Pakistan
94.8 %
29,066 95.1 % 32,526 94.8 % +11.90%
Sri Lanka
1.9 %
604 2.0 % 641 1.9 % +6.08%
Myanmar
1.0 %
333 1.1 % 346 1.0 % +3.73%
Cambodia
0.8 %
209 0.7 % 271 0.8 % +29.74%
Vietnam
0.5 %
127 0.4 % 186 0.5 % +46.78%
Iraq
0.3 %
32 0.1 % 90 0.3 % +186.56%
Oman
0.2 %
28 0.1 % 84 0.2 % +201.59%
Others
0.2 %
40 0.1 % 53 0.2 % +30.65%
Afghanistan
0.2 %
70 0.2 % 52 0.2 % -25.59%
Tajikistan
0.1 %
-- 28 0.1 % -
Laos
0.1 %
22 0.1 % 25 0.1 % +15.04%
Kenya
0.0 %
23 0.1 % 14 0.0 % -41.23%

Managers

Managers TitleAgeSince
Chief Executive Officer - 07-12-31
Director of Finance/CFO - 14-10-22
Chief Tech/Sci/R&D Officer - 15-12-31
Director/Board Member - -
Director/Board Member 60 -
Investor Relations Contact - -
Sales & Marketing - 13-05-31
Human Resources Officer - -
Sales & Marketing - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer - 07-12-31
Director/Board Member 60 -
Director/Board Member - 21-02-25
Chairman - -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - 23-10-26
Director/Board Member - 23-10-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 511,494,426 302,124,789 ( 59.07 %) 0 59.07 %

Shareholders

NameEquities%Valuation
National Investment Trust Ltd.
1.564 %
7,998,227 1.564 % 2 M ₨
NBP Fund Management Ltd.
0.2193 %
1,121,703 0.2193 % 211 026 ₨
Faysal Bank Ltd. (Investment Management)
0.2167 %
1,108,625 0.2167 % 208 566 ₨
Al Meezan Investment Management Ltd.
0.1803 %
922,101 0.1803 % 173 475 ₨
Alfalah Asset Management Ltd.
0.0363 %
185,611 0.0363 % 34 919 ₨
UBL Fund Managers Ltd.
0.0333 %
170,191 0.0333 % 32 018 ₨
MCB-Arif Habib Savings & Investments Ltd. (Invt Mgmt)
0.0189 %
96,573 0.0189 % 18 168 ₨
AKD Investment Management Ltd.
0.0122 %
62,463 0.0122 % 11 751 ₨
HBL Asset Management Ltd.
0.005695 %
29,129 0.005695 % 5 480 ₨
First Capital Investments Ltd.
0.002832 %
14,486 0.002832 % 2 725 ₨

Company contact information

The Searle Co. Ltd.

One IBL Centre, Tipu Sultan Road 2nd Floor, Plot No. 1, Block 7 & 8

75530, Karachi

+

http://searlecompany.com
address The Searle Company Limited(SEARL)

Sales per region

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
56.53 PKR
Average target price
65 PKR
Spread / Average Target
+14.98%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SEARL Stock
  4. Company The Searle Company Limited